ENETS Task Forces & Working Groups

In 2021, ENETS streamlined its various scientific activities into two categories: task forces and working groups. Task forces are established groups whose aim is to answer scientific questions. Standing working groups, on the other hand, have been established to address topics such as ENETS education, ENETS database, and the ENETS Centers of Excellence (CoE) programme.

ENETS Task Forces

The task forces aim to tackle complex clinical and scientific challenges while advancing ENETS research. Each task force comprises a variable structure, bringing together Advisory Board members, leading experts in the field—including those from outside the Advisory Board—and representatives from various countries. These groups adopt a multi-disciplinary approach.

Current task forces include:

  • Theranostics in NEN
  • High grade NEN G3
  • Clinical trials
  • Lung NET
  • MEN-1
  • Carcinoid Heart Disease (CHD)

 

CHD task force leaflet

The ENETS CHD task force has compiled a leaflet for patients suffering from CHD. To find out more about this disease, click on the link below.

read now

ENETS Task Force Publications


MEN1 Task Force

"Screening and surveillance practices for Multiple Endocrine Neoplasia type 1-related Neuroendocrine Tumours in European Neuroendocrine Tumor Society Centers of Excellence (ENETS CoE) — An ENETS MEN1 task force questionnaire study"

Published in the Journal of Neuroendocrinology on 26 November 2024.

Read article

___________________________________________________________________________________________________

Lung NET Task Force

"Clinical management of typical and atypical carcinoids/neuroendocrine tumors in ENETS centres of excellence (CoE): Survey from the ENETS lung NET task force."

Published in the Journal of Neuroendocrinology on 16 May 2024.

Read article

___________________________________________________________________________________________________

Theranostics Task Force

"Use and perceived utility of [18F]FDG PET/CT in neuroendocrine neoplasms: A consensus report from the European Neuroendocrine Tumor Society (ENETS) Advisory Board Meeting 2022."

Published in the Journal of Neuroendocrinology on 14 December 2023.

Read article

 

ENETS Working Groups

ENETS Database

ENETS has a long experience in rare tumors and has a high level of expertise and multi-center cooperation resulting from its networking with ENETS certified centers of (ENETS Centers of Excellence - CoE) in Europe as well as non-European countries, such as the USA, Australia, and others. ENETS has hosted a registry for neuroendocrine tumors since 2008.

learn more

ENETS Education

This newly-established working group focuses on ENETS’ continuous education programme in 2021 and beyond. The aim of this group is to restructure and streamline all ENETS educational activities, including physical and virtual learning activities. The group set up the ENETS webinar series in 2021, which has been accredited by the UEMS.

learn more about the ENETS webinar series

ENETS/UEMS NEN Specialist Curriculum

ENETS has been working closely with the UEMS to establish the European Training Requirements (ETR) for the MJC/RUD NEN (for trainees, trainers, and training centers). The ETR was approved by the UEMS Council in July 2020. Subsequently, the UEMS also approved to set up a multidisciplinary joint committee (MJC) for neuroendocrine neoplasia medicine.